Maura Gillison
Internal Medicine
Credentials: · · · · · ·
History
- 1994–1996
Medical Oncology
- 1991–1994
Internal Medicine
- 1987–1991
Research
Human papillomavirus and survival of patients with oropharyngeal cancer
New England Journal of Medicine · 2010 · Last of 15 authors · 5,362 citations
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
New England Journal of Medicine · 2016 · Last of 23 authors · 4,100 citations
Human papillomavirus and rising oropharyngeal cancer incidence in the United States
Journal of Clinical Oncology · 2011 · Last of 18 authors · 2,917 citations
30 papers · 6 as a resident
25 papers
23 papers
David Rosenthal
21 papers
21 papers
21 papers
- JR
20 papers
- JC
Jimmy Caudell
18 papers
Grants
- 2019–2024
Functional Consequences of Mutations in Spliceosomal Small Nuclear RNAs
National Institute of General Medical Sciences · R01
PI · $472.5K · Cleveland Clinic Lerner Com-Cwru
- 2012–2015
Prevalence and Determinants of Oral Hpv Infection in the Us Population
National Institute of Dental and Craniofacial Research · R01
Contact PI · $1.5M · Ohio State University
- 2005–2011
Oral HPV Infection in HIV-Infected Men and Women
National Institute of Dental and Craniofacial Research · R01
Contact PI · $2.5M · Ohio State University
- 2007–2011
A Therapeutic Vaccine for HPV 16-Positive Head and Neck Cancer
National Cancer Institute · R21
Contact PI · $486.7K · Ohio State University
Clinical trials
- 2021–2026
Principal investigator · Active not recruiting · Phase 1
National Cancer Institute (NCI)
- 2016–2022
Principal investigator · Completed · Phase 1
RTOG Foundation, Inc.
- 2011–2018
Preoperative Treatment With Cetuximab and/or IMC-A12
Principal investigator · Completed · Phase 2
M.D. Anderson Cancer Center
- 2011–2025
Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer
Principal investigator · Completed · Phase 3
Radiation Therapy Oncology Group